Postgrad LIVE! Study Fairs

Birmingham | Edinburgh | Liverpool | Sheffield | Southampton | Bristol

University of East Anglia Featured PhD Programmes
Swansea University Featured PhD Programmes
University of Sussex Featured PhD Programmes
University of Kent Featured PhD Programmes
University College London Featured PhD Programmes
"reprogramming"×
10 miles

reprogramming PhD Projects, Programs & Scholarships

We have 24 reprogramming PhD Projects, Programs & Scholarships

  • "reprogramming" ×
  • clear all
Order by 
Showing 1 to 10 of 24
  Metabolic reprogramming and chemotherapy resistance in triple-negative breast cancer
  Dr K Brown
Applications accepted all year round
Treatment options for the triple-negative breast cancer (TNBC) subtype of breast cancer are limited to conventional chemotherapy agents.
  Fishing for metabolic clues: Role of the Hippo/Yap pathway in reprogramming metabolism in liver cancer
  Dr A. Cox
Applications accepted all year round
The Hippo/Yap pathway is an evolutionarily conserved cascade that plays a fundamental role in governing organ size control, stem cell homeostasis and cancer.
  Cutting off the fuel supply to starve cancer: Identifying metabolic vulnerabilities in cancer
  Dr K Brown, Dr A. Cox
Applications accepted all year round
A universal characteristic of all cancer cells is the reprogramming of cell metabolism to provide the energy and building blocks necessary to support proliferation and survival.
  Metabolic Reprogramming in Liver Cancer: delineating the role of reactive oxygen species (ROS) in tumour development
  Prof T. Tiganis
Applications accepted all year round
The Tiganis Laboratory is seeking a highly enthusiastic student to conduct research in cancer metabolism and obesity-associated liver cancer.
  FOXA1 mutations in Lobular Breast Cancer: Reprogramming Responses to Tamoxifen
  Prof D Heery, Dr S Johnston
Applications accepted all year round
Tumours of the breast are often hormone-dependent, meaning their growth is driven by steroid hormones such as estrogen. This hormone acts upon the estrogen receptor (ER), which together with other transcription factors such as FOXA1 drives tumour growth.
  Defining the role of mitochondrial dysfunction in therapy resistance inKRAS mutant colorectal cancer models
  Research Group: Centre for Cancer Research and Cell Biology
  Dr E Kerr, Dr I Mills
Application Deadline: 30 January 2019
Mutant KRAS driven metabolic reprogramming is a key hallmark of cancer, providing the building blocks necessary to support aberrant cancer cell proliferation and is often achieved through rewiring glycolytic, mitochondrial and fatty acid metabolism, reportedly leading to mitochondrial dysfunction.
  Metabolic rewiring in liver cancer: Role of oxidative stress and the Nrf2 pathway
  Dr A. Cox
Applications accepted all year round
Many of the major risks factors for developing liver cancer such as alcohol, obesity, smoking and toxin exposure share in common a role for oxidative stress.
  Mybl2 in the regulation of cell fate decisions
  Dr P Garcia
Applications accepted all year round
We are interested in the molecular mechanisms regulating cell fate decisions that occur during normal development, somatic reprogramming and cancer.
  Epitranscriptomic mechanisms in the maternal to zygotic transition of vertebrate embryos
  Research Group: BBSRC MIBTP
  Dr M Soller, Prof F Mueller
Applications accepted all year round
Most mRNAs contain modified nucleotides in mRNA, but we know very little about their function (Haussmann et al, 2016, Dezi et al, 2016, Roignant and Soller, 2017).
  Modelling the interface of metabolism, methylation and mitochondria in prostate cancer
  Prof A Lynch
Applications accepted all year round
The interface of metabolism, methylation and mitochondria is of key importance for understanding the aetiology, biology and prognosis of prostate cancer[1].
Show 10 15 30 per page


FindAPhD. Copyright 2005-2018
All rights reserved.